# Developmental Funds

> **NIH NIH P30** · CASE WESTERN RESERVE UNIVERSITY · 2022 · $978,906

## Abstract

DEVELOPMENTAL FUNDS
PROJECT SUMMARY/ABSTRACT
The use of developmental funds is crucial for the Case Comprehensive Cancer Center (Case CCC), providing
discretionary support for strategic priorities and augmenting its Research Programs and new initiatives. In the
current grant cycle, funds have supported recruitments, emerging technology Shared Resources (SRs), and
Research Program-aligned and prioritized pilot projects. In addition, the institutional support for additional
resources that expand the research scope and accomplishments has increased substantially over the grant
period. The Specific Aims of the Developmental Funds are to:
 1. Support high impact recruitments across the Center who will establish Research Programs that aim to
 provide basic, translational and/or clinical impact to cancer research in terms of the etiology of cancer,
 prevention, detection and treatment.
 2. Support innovative infrastructure emerging as new Shared Resources that enable investigators to
 conduct high quality transdisciplinary research.
 3. Support new research initiatives aligned with the Center’s Strategic Plan and coordinated through its
 Research Programs that advance new discoveries towards high-impact, and that emphasize
 collaborative efforts across programs and disciplines.
 4. Support early-phase clinical investigation through support for clinical investigators and support for
 clinical trials staff that manage these early-phase studies.
 5. Continue to leverage CCSG developmental fund investments with institutional support to expand the
 program effort and speed its overall impact across the Center.
Use of developmental funds will be aligned with the Case CCC’s Strategic Plan and coordinated through the
Executive Committee. Funds will be used to support the following activities: i) Recruitments: the Center will
identify two recruitments per year with augmented packages; ii) New Shared Resource Initiatives: the Center
will use funds to help develop new Shared Resources; iii) Pilot Grants: grants will be awarded to each
Research Program that are collaborative and interdisciplinary in order to encourage large multi-investigator
initiatives; iv) Early Phase Therapeutics: up to three clinical investigators will be supported at 20% effort each
and clinical trials support staff will be supported to facilitate investigator-initiated clinical trials.

## Key facts

- **NIH application ID:** 10380723
- **Project number:** 5P30CA043703-32
- **Recipient organization:** CASE WESTERN RESERVE UNIVERSITY
- **Principal Investigator:** STANTON L. GERSON
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $978,906
- **Award type:** 5
- **Project period:** 1997-08-01 → 2023-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10380723

## Citation

> US National Institutes of Health, RePORTER application 10380723, Developmental Funds (5P30CA043703-32). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10380723. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*